Hepatocarcinoma

Hepatocellular carcinoma is the most frequent malignant primary liver tumor that is generally found on the cirrhotic liver. There are different risk populations that determine the need to carry out screening strategies for early diagnosis. In cirrhotic patients, it is recommended to perform an ultrasound graph every six months. Diagnoses of the hepatocarcinoma is made using dynamic imaging tests. Detection on the four-dimension phase computed tomography or magnetic angioresonance of a hypervascular node in arterial phase and with early washout in the phase is diagnostic of hepatocarcinoma is performed. The BCLC staging system allows classification of the patients based on the tumor characteristics and those of the hepatic disease, and facilitates assigning therapeutic attitudes. Surgery, percutaneous ablation and liver transplant are alternatives with applicable curative intention in patients in early stages. Sorafenib is a multikinase inhibitor that improves survival in patients with advanced tumors.